Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosilate vs Propofol for General Anesthesia
NCT02406872Phase 2Completed
- Sponsor
- Hengrui
- Start
- Dec 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of remimazolam in general anesthesia (4 arms), sponsored by Hengrui. Primary endpoint: Successful Anaesthesia Rate at 3 hours. Started Dec 2014; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT02406872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406872.